Capital Impact Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.21M | Buy |
+83,678
| New | +$7.51M | 2.91% | 16 |
|
|
2025
Q3 | – | Sell |
-86,735
| Closed | -$5.12M | – | 34 |
|
|
2025
Q2 | $5.12M | Buy |
86,735
+2,966
| +4% | +$192K | 1.54% | 30 |
|
|
2025
Q1 | $6.13M | Buy |
+83,769
| New | +$6.92M | 2.35% | 27 |
|
|
2024
Q3 | – | Sell |
-19,858
| Closed | -$1.36M | – | 22 |
|
|
2024
Q2 | $1.36M | Sell |
19,858
-8,088
| -29% | -$483K | 3.83% | 2 |
|
|
2024
Q1 | $1.5M | Buy |
27,946
+18,594
| +199% | +$1,000K | 1.95% | 9 |
|
|
2023
Q4 | $498K | Hold |
9,352
| – | – | 0.65% | 72 |
|
|
2023
Q3 | $464K | Sell |
9,352
-3,510
| -27% | -$196K | 0.78% | 63 |
|
|
2023
Q2 | $766K | Buy |
12,862
+6,149
| +92% | +$350K | 0.84% | 34 |
|
|
2023
Q1 | $380K | Sell |
6,713
-11,172
| -62% | -$716K | 0.47% | 101 |
|
|
2022
Q4 | $1.33M | Sell |
17,885
-381
| -2% | -$25.9K | 1.3% | 1 |
|
|
2022
Q3 | $1.21M | Buy |
18,266
+53
| +0.3% | +$3.19K | 1.21% | 5 |
|
|
2022
Q2 | $1.02M | Sell |
18,213
-2,662
| -13% | -$175K | 0.94% | 7 |
|
|
2022
Q1 | $1.54M | Buy |
20,875
+894
| +4% | +$62.1K | 1.12% | 8 |
|
|
2021
Q4 | $1.44M | Buy |
+19,981
| New | +$1.45M | 1% | 36 |
|
|
2018
Q1 | – | Sell |
-46,636
| Closed | -$1.92M | – | 135 |
|
|
2017
Q4 | $1.92M | Hold |
46,636
| – | – | 0.83% | 35 |
|
|
2017
Q3 | $1.39M | Buy |
46,636
+14,983
| +47% | +$457K | 0.62% | 72 |
|
|
2017
Q2 | $1.05M | Sell |
31,653
-12,126
| -28% | -$381K | 0.48% | 115 |
|
|
2017
Q1 | $1.3M | Sell |
43,779
-20,147
| -32% | -$550K | 0.52% | 107 |
|
|
2016
Q4 | $1.59M | Hold |
63,926
| – | – | 0.66% | 24 |
|
|
2016
Q3 | $1.44M | Buy |
63,926
+24,300
| +61% | +$571K | 0.62% | 31 |
|
|
2016
Q2 | $944K | Hold |
39,626
| – | – | 0.44% | 96 |
|
|
2016
Q1 | $941K | Buy |
39,626
+8,817
| +29% | +$216K | 0.45% | 88 |
|
|
2015
Q4 | $857K | Hold |
30,809
| – | – | 0.41% | 93 |
|
|
2015
Q3 | $637K | Hold |
30,809
| – | – | 0.32% | 123 |
|
|
2015
Q2 | $791K | Hold |
30,809
| – | – | 0.36% | 115 |
|
|
2015
Q1 | $778K | Sell |
30,809
-32,216
| -51% | -$785K | 0.36% | 116 |
|
|
2014
Q4 | $1.5M | Hold |
63,025
| – | – | 0.71% | 52 |
|
|
2014
Q3 | $1.24K | Hold |
63,025
| – | – | ﹤0.01% | 65 |
|
|
2014
Q2 | $1.51M | Hold |
63,025
| – | – | 1.14% | 23 |
|
|
2014
Q1 | $1.68M | Hold |
63,025
| – | – | 1.35% | 19 |
|
|
2013
Q4 | $1.27M | Buy |
+63,025
| New | +$1.17M | 1.02% | 40 |
|
Other funds holding GMED
VCM
VPM
SC
Capital Impact Advisors's GMED Position: Q1 2026 in Review
Capital Impact Advisors opened a new position in Globus Medical (GMED) in Q1 2026: 83,678 shares worth $7.21M. The stake represents 2.91% of the portfolio and ranks #16 among its holdings. This is a return to the name: Capital Impact Advisors previously reported a position in GMED as recently as Q2 2025.
Capital Impact Advisors first reported a position in GMED in Q4 2013 and has held it in 31 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Capital Impact Advisors held 83,678 shares of Globus Medical worth $7.21M as of Q1 2026.
- Globus Medical was a new Capital Impact Advisors position in Q1 2026.
- Globus Medical made up 2.91% of Capital Impact Advisors's portfolio in Q1 2026, its #16 holding.
- Capital Impact Advisors first reported a position in Globus Medical in Q4 2013 and has held it in 31 quarters since.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Capital Impact Advisors's 13F filing for Q1 2026, filed 15 May 2026.